Calcium Chloride Injection
NDC Package 70518-4180-0

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Calcium Chloride injection is 10% Calcium Chloride Injection, USP is indicated for the treatment of hypocalcemia in those conditions requiring a prompt increase in plasma calcium levels. This formulation utilizes a injection delivery system. Marketed by Remedyrepack Inc., this product is identified by NDC 70518-4180 and is authorized under FDA application ANDA203477.

Identification & Billing

NDC Package Code
70518-4180-0
Package Description
10 SYRINGE in 1 PACKAGE / 10 mL in 1 SYRINGE (70518-4180-1)
Product Code
70518-4180
11-Digit Billing Format
70518418000
RxNorm Crosswalk
  • RxCUI: 828527 - calcium chloride 10 % in 10 ML Prefilled Syringe
  • RxCUI: 828527 - 10 ML calcium chloride 100 MG/ML Prefilled Syringe

Clinical Specifications

Proprietary Name
Calcium Chloride
Non-Proprietary Name
Calcium Chloride
Substance Name
Calcium Chloride
Dosage Form
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route
  • Intravenous - Administration within or into a vein or veins.
  • Intraventricular - Administration within a ventricle.
Active Ingredient(s)
CALCIUM CHLORIDE 100 mg/mL
Pharmacologic Class
Usage Information
10% Calcium Chloride Injection, USP is indicated for the treatment of hypocalcemia in those conditions requiring a prompt increase in plasma calcium levels.

Regulatory & Marketing

Labeler Name
Remedyrepack Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA203477
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
09-24-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70518-4180-0 identifies a specific commercial package of 10 syringe in 1 package / 10 ml in 1 syringe (70518-4180-1) of Calcium Chloride, a human prescription drug labeled by Remedyrepack Inc.. This injection is formulated for intravenous; intraventricular use and contains calcium chloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Remedyrepack Inc. on September 24, 2024. The current certification is valid through December 31, 2026.

How is this Remedyrepack Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70518418000. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
70518-4180-0
11-Digit CMS (5-4-2)
70518-4180-00

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.